Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 16, Number 11—November 2010


Enhanced Surveillance of Coccidioidomycosis, Arizona, USA, 2007–2008

Clarisse A. TsangComments to Author , Shoana M. Anderson, Sara B. Imholte, Laura M. Erhart, Sanny Chen, Benjamin J. Park, Cara Christ, Kenneth K. Komatsu, Tom M. Chiller, and Rebecca H. Sunenshine
Author affiliations: Arizona Department of Health Services, Phoenix, Arizona, USA (C.A. Tsang, S.M. Anderson, S.B. Imholte, L.M. Erhart, S. Chen, C. Christ, K.K. Komatsu, R.H. Sunenshine); Centers for Disease Control and Prevention, Atlanta, Georgia, USA (S. Chen, B.J. Park, T. Chiller, R.H. Sunenshine)

Main Article

Table 3

Characteristics of enhanced surveillance coccidioidomycosis patients, and statewide hospital charges identified through the 2007 Arizona Hospital Discharge Database

Description Mean Median Range Interquartile range Total
Days from symptom onset to diagnosis date, n = 422 209 55 0–10,280 22–143
Days from first seeking health care to diagnosis date, n = 422 156 23 0–10,280 6–74
Days of symptom duration,* n = 420 202 120 0–5,224 49–198
Days missed from work,† n = 159 31 14 0–365 5–30
Days missed from school,‡ n = 35 17 9 0–120 3–15
Days unable to perform daily activities,§ n = 352 96 47 0–1,825 15–120
Per visit hospital charges for coccidioidomycosis primary diagnoses, n = 1,093 $54,000 $33,000 $113–$1,474,795 $59 million
Per visit hospital charges for coccidioidomycosis primary or secondary diagnoses, n = 1,735 $49,000 $30,000 $113–$1,474,795 $86 million

*Symptom duration analysis includes patients who had recovered and those who had not yet recovered from their symptoms at the time of interview.
†Number of days missed from work was available for 159/167 patients who reported that they missed work due to their disease.
‡Number of days missed from school was available for 35/37 patients who reported that they missed school due to their disease.
§Number of days patients were unable to perform daily activities was available for 352/369 patients who reported that their disease interfered with their daily activities.

Main Article